Since we had observed activation of the p53 target gene Cdkn1a in Ddx41+/− HSPCs, we sought to determine the contribution of p53 activity to hematologic disease in the context of Ddx41 mutations. This evidence concerns the gene DDX41 and hematologic disorder.